These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9038325)

  • 1. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.
    Duffy PE; Kaslow DC
    Infect Immun; 1997 Mar; 65(3):1109-13. PubMed ID: 9038325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.
    Gozar MM; Price VL; Kaslow DC
    Infect Immun; 1998 Jan; 66(1):59-64. PubMed ID: 9423839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
    Sookpongthai P; Utayopas K; Sitthiyotha T; Pengsakul T; Kaewthamasorn M; Wangkanont K; Harnyuttanakorn P; Chunsrivirot S; Pattaradilokrat S
    Parasit Vectors; 2021 Nov; 14(1):571. PubMed ID: 34749796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.
    Gregory JA; Li F; Tomosada LM; Cox CJ; Topol AB; Vinetz JM; Mayfield S
    PLoS One; 2012; 7(5):e37179. PubMed ID: 22615931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.
    Kumar R; Angov E; Kumar N
    Infect Immun; 2014 Apr; 82(4):1453-9. PubMed ID: 24421036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
    Mlambo G; Maciel J; Kumar N
    Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230.
    Williamson KC; Kaslow DC
    Mol Biochem Parasitol; 1993 Nov; 62(1):125-7. PubMed ID: 8114814
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
    Li Y; Leneghan DB; Miura K; Nikolaeva D; Brian IJ; Dicks MD; Fyfe AJ; Zakutansky SE; de Cassan S; Long CA; Draper SJ; Hill AV; Hill F; Biswas S
    Sci Rep; 2016 Jan; 6():18848. PubMed ID: 26743316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design.
    Shukla N; Tang WK; Tolia NH
    Sci Rep; 2022 Nov; 12(1):19556. PubMed ID: 36379968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Plasmodium falciparum sexual stage antigens: implications for the design of a transmission blocking vaccine.
    Kaslow DC
    Immunol Lett; 1990 Aug; 25(1-3):83-6. PubMed ID: 1704352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
    Healy SA; Anderson C; Swihart BJ; Mwakingwe A; Gabriel EE; Decederfelt H; Hobbs CV; Rausch KM; Zhu D; Muratova O; Herrera R; Scaria PV; MacDonald NJ; Lambert LE; Zaidi I; Coelho CH; Renn JP; Wu Y; Narum DL; Duffy PE
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
    Healer J; McGuinness D; Carter R; Riley E
    Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen.
    Mlambo G; Kumar N; Yoshida S
    Vaccine; 2010 Oct; 28(43):7025-9. PubMed ID: 20709008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus.
    Kaslow DC; Isaacs SN; Quakyi IA; Gwadz RW; Moss B; Keister DB
    Science; 1991 May; 252(5010):1310-3. PubMed ID: 1925544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
    Goodman AL; Blagborough AM; Biswas S; Wu Y; Hill AV; Sinden RE; Draper SJ
    PLoS One; 2011; 6(12):e29428. PubMed ID: 22216279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
    Barr PJ; Green KM; Gibson HL; Bathurst IC; Quakyi IA; Kaslow DC
    J Exp Med; 1991 Nov; 174(5):1203-8. PubMed ID: 1940798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
    Coban C; Philipp MT; Purcell JE; Keister DB; Okulate M; Martin DS; Kumar N
    Infect Immun; 2004 Jan; 72(1):253-9. PubMed ID: 14688103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
    McGuire KA; Miura K; Wiethoff CM; Williamson KC
    Malar J; 2017 Jun; 16(1):254. PubMed ID: 28619071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.